---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-032692"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:07:06.737216+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Syra Health receives Nasdaq delisting notice for equity shortfall; provides 2024 revenue guidance of $7.5-9.5M

## Summary
- Nasdaq notified Syra Health of non-compliance with stockholders' equity minimum of $2.5M (Listing Rule 5550(b)(1)).
- Company has 45 days to submit a compliance plan; Nasdaq may grant up to 180-day extension.
- Full-year 2024 revenue forecast $7.5-9.5M (36%-73% YoY growth), with majority in H2 due to delayed implementation.
- If compliance plan not accepted, stock could be delisted; company can appeal.

## SEC filing metadata
- accession: 0001493152-24-032692
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315224032692/0001493152-24-032692-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315224032692/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-032692
- JSON: https://secwatch.observer/filing/0001493152-24-032692.json
- Plain text: https://secwatch.observer/filing/0001493152-24-032692.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.